Advisory Services Network’s Aldeyra Therapeutics ALDX Stock Holding History

Advisory Services Network’s Portfolio ALDX Stock Details ALDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-500	Closed	-$1.75K	–	1508
2023 Q4	$1.75K	Buy	+500	New	+$1.54K	﹤0.01%	3425
2021 Q3	–	Sell	-1,115	Closed	-$13K	–	1438
2021 Q2	$13K	Buy	+1,115	New	+$13.4K	﹤0.01%	2668
2021 Q1	–	Sell	-1,115	Closed	-$8K	–	1330
2020 Q4	$8K	Hold	1,115	–	–	﹤0.01%	2524
2020 Q3	$8K	Buy	+1,115	New	+$7.2K	﹤0.01%	2536

Other funds holding ALDX

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Advisory Services Network's ALDX Position: Q1 2024 in Review

Advisory Services Network sold out of Aldeyra Therapeutics (ALDX) in Q1 2024, closing a stake of 500 shares — an estimated $1.75K sold.

Advisory Services Network first reported a position in ALDX in Q3 2020 and held it in 4 quarters. The position peaked at $13K in Q2 2021. 102 funds tracked by Wall St. Rank hold ALDX as of Q1 2024.

Advisory Services Network reported no remaining Aldeyra Therapeutics position as of Q1 2024 after selling out during the quarter.
Advisory Services Network sold 500 Aldeyra Therapeutics shares in Q1 2024, an estimated $1.75K.
Advisory Services Network first reported a position in Aldeyra Therapeutics in Q3 2020 and held it in 4 quarters.
Advisory Services Network's Aldeyra Therapeutics position peaked at $13K in Q2 2021.
102 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.